Log In
Print
BCIQ
Print
Print this Print this
 

Fluenz, FluMist (live attenuated influenza vaccine (LAIV))

Also known as: FluMist vaccine

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionIntranasal live attenuated trivalent influenza
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza in immunocompromised children with cancer; Prevent influenza infection in healthy children and adults ages 5-49; Prevent influenza infection in HIV-infected children; Vaccinate against seasonal influenza virus; Vaccinate against seasonal influenza virus infection in children <24 months of age or in children 24-59 months of age with asthma, wheezing or altered immunocompetence; Vaccinate against seasonal influenza virus infection in children >24 months of age or <18 years of age; Vaccinate against swine influenza A (H1N1)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today